Biolargo Inc

Good afternoon, ladies and gentlemen, and welcome to the BioLargo year-end 2021 earnings results conference call. At this time, all participants have been placed on a listen-only mode. It is now my pleasure to turn the floor over to your host, Brian Loper. Sir, the floor is yours.

Thank you, operator. I appreciate that. Good afternoon, everyone, and welcome to BioLargo's 2021 annual results conference call. By now, everyone should have had access to the earnings press release, which was issued last Thursday prior to market open, and the annual report filed at the SEC. This call is being webcast and is available for replay. In our remarks today, we may include statements that are considered forward-looking within the meanings of securities laws, including forward-looking statements about future results of operations, business strategies and plans, our relationships with our customers, market and potential growth opportunities. In addition, management may make additional forward-looking statements in response to your questions. Forward-looking statements are based on management's current knowledge and expectations as of today and are subject to certain risks and uncertainties and may cause the actual results to differ materially from the forward-looking statements. A detailed discussion of such risks and uncertainties are contained in our most recent Form 10-K, Form 10-Q, and in other reports filed at the SEC. The company undertakes no obligation to update any forward-looking statements. And with that, I'll now hand the call over to BioLargo's Chief Executive Officer, Dennis Calvert.

Hey, Brian, and thank you, everyone. I'm glad you're here. We've got a lot to cover, and we also have Charlie Dargan, our CFO, joining us today. Charlie, can you say hello?